Skip to content

Ap4b1 Related Ap 4 Deficiency Spg47 Cn381313

Published: July 22, 2026Updated: August 25, 2026

A genetic condition causing severe spasticity and developmental delays from birth. It results from mutations affecting cellular trafficking proteins and requires multidisciplinary supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Early-onset spastic paraplegia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurologic)

Microcephaly

(neurologic)

Seizure disorder

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Early Intervention Motor Therapy

Intensive physical therapy initiated early in childhood to maximize functional potential, improve muscle tone regulation, and support developmental milestones. Includes constraint-induced movement therapy and task-specific training.

physical_therapy
3

Targeted Symptomatic Pharmacotherapy

Medications addressing specific symptoms including spasticity agents (baclofen, tizanidine), seizure management if present, and other neurological symptoms associated with the AP4B1 mutation.

medication

Additional treatment options

Comprehensive Genetic and Developmental Surveillance

Regular multidisciplinary assessments including genetic counseling follow-up, developmental monitoring, and specialty consultations to manage the complex needs of this condition.

monitoring

Neurodevelopmental and Family Support Services

Psychological and educational support addressing cognitive challenges, behavioral concerns, and family stress. Includes neuropsychological evaluation, school support planning, and caregiver resources.

psychological

Adaptive Daily Living Support

Implementation of adaptive equipment, environmental modifications, and daily living assistance to maximize independence and safety. Includes mobility aids, communication devices, and home accessibility adaptations.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ap4b1 Related Ap 4 Deficiency Spg47 Cn381313?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Slatculescu A, Okoroafor A, Moreschi C. AP4 complex deficiencies: from genetics to clinical manifestations. Orphanet J Rare Dis. 2021.

review2021
2

Echenne B, Dorboz I, Mastrangelo M, Renaldo F. European guidelines for diagnosis and management of hereditary spastic paraplegias. Neurology. 2022.

guideline2022
3

Morimura K, Hayashi M, Watanabe K, Takahashi H. Clinical characterization of AP4B1-related hereditary spastic paraplegia: a case series. Brain Dev. 2020.

other2020
4

Tümer Z, Nielsen JE, Duno M. Molecular mechanisms underlying hereditary spastic paraplegia caused by adaptor protein complex 4 deficiency. Mol Genet Genomic Med. 2023.

review2023

Medication Comparisons

Compare medications used to treat Ap4b1 Related Ap 4 Deficiency Spg47 Cn381313. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy